Teikoku Pharma USA, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.teikokuusa.com
Clinical Trials
14
Active:7
Completed:4
Trial Phases
2 Phases
Phase 2:6
Not Applicable:1
Drug Approvals
1
NMPA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (85.7%)Not Applicable
1 (14.3%)Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Phase 2
Not yet recruiting
- Conditions
- Agitation
- Interventions
- Drug: 6 cm2 - 1 Active and 1 Placebo DMTS PatchesDrug: Placebo - 2 Placebo DMTS PatchesDrug: 12 cm2 - 2 Active DMTS Patches
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06052254
Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty
Phase 2
- Conditions
- Pain, Postoperative
- Interventions
- Drug: DMTS PatchDrug: Placebo Patch
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 182
- Registration Number
- NCT05412992
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty
Phase 2
- Conditions
- Pain, Postoperative
- Interventions
- Drug: DMTSDrug: Placebo
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 164
- Registration Number
- NCT04242407
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸HD Research, Bellaire, Texas, United States
🇺🇸Endeavor Clinical Trials, San Antonio, Texas, United States
Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy
Phase 2
Completed
- Conditions
- Pain, Postoperative
- Interventions
- Drug: PlaceboDrug: DMTS
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT02953054
- Locations
- 🇦🇺
Nucleus Network LTD, Melbourne, Victoria, Australia
🇦🇺Linear Clinical Research, Nedlands, Western Australia, Australia
Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
Phase 2
Completed
- Conditions
- Irritation/Irritant
- Interventions
- Drug: 350 mg Donepezil Transdermal PatchDrug: Placebo Patch
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT00916383
- Locations
- 🇺🇸
Xenoscience, Inc, Phoenix, Arizona, United States
🇺🇸Margolin Brain Institute, Fresno, California, United States
🇺🇸Collaborative Neuroscience Network, Inc, Garden Grove, California, United States
- Prev
- 1
- 2
- Next
News
No news found